Are childhood vaccines really skipping the rigorous testing we assume they get?

SUMMARY The FactCheck.org article examines the recurring assertion, recently repeated by Del Bigtree at a March 9, 2026 conference and by HHS Secretary Robert F. Kennedy Jr. over years, that childhood vaccines on the CDC schedule have not undergone double-blind placebo-controlled trials prior to licensure. It concludes this claim is misleading because it misunderstands the vaccine safety testing process and applies a narrow definition of “placebo” that insists exclusively on inert saline. Scientists quoted in the piece explain that ethical standards often require active comparators (existing vaccines or matching formulations with adjuvants) once effective vaccines exist, while initial trials for many vaccines did use placebo controls, with safety further confirmed through large-scale observational data and post-licensure surveillance.[1][2]

EVIDENCE Evidence confirms that many childhood vaccines, including the original polio, measles, varicella, HPV, and rotavirus vaccines, were evaluated in randomized placebo-controlled trials, some using inert or near-inert controls.[3][4] This is contradicted by the narrow insistence that only saline qualifies as a true placebo and that “no placebo trial” exists anywhere; multiple sources document the use of appropriate controls for both scientific blinding and ethical reasons. Sources are divided on whether non-inert controls sufficiently isolate all possible signals (particularly adjuvants), but mainstream scientific bodies, trial publications, and experts from institutions such as Johns Hopkins, CHOP, Vanderbilt, and the University of Pennsylvania affirm that the overall safety testing process is rigorous and that claims of completely untested vaccines distort the record.[1][5] The specific quotes attributed to Del Bigtree and the description of his ties to RFK Jr. are directly supported by the conference video and public records. Missing context in the broader debate includes ongoing activist arguments (via ICAN FOIA and package-insert reviews) that many pivotal trials used adjuvanted or antigen-containing controls rather than pure saline, potentially masking certain cumulative effects.[1]

ASSESSMENT WELL SOURCED. The article accurately reports the speakers’ statements, grounds its critique in clinical trial records, ethical guidelines, and expert consensus, and explains the distinction between inert and active controls without fabricating data.

CRITICAL CONTEXT Uncertainties remain about whether current post-licensure observational systems (VAERS, VSD) fully capture rare or long-term cumulative effects compared with very large pre-licensure inert-placebo trials; some trial designs intentionally matched inactive ingredients or used other vaccines to maintain blinding and provide benefit, which critics argue limits detection of certain signals. Policy changes under current HHS leadership mandating inert placebo testing for new vaccines implicitly acknowledge gaps in past approaches for future products, while a federal judge has blocked related alterations to the childhood schedule. The article focuses primarily on debunking the absolute claim rather than exhaustively quantifying every adjuvant-related study.

INSTITUTIONAL CONTEXT Documented prior failures in pharmaceutical regulation and public-health oversight include the opioid epidemic, in which Purdue Pharma misrepresented OxyContin’s addiction risk with FDA approval, fueling widespread misuse and deaths; Merck’s Vioxx, approved in 1999 and withdrawn in 2004 after cardiovascular risks were downplayed, with estimates of tens of thousands of associated deaths; and the thalidomide tragedy of the late 1950s–early 1960s, where inadequate pre-market testing led to severe birth defects before stricter regulations were enacted. These concrete examples of regulatory capture, suppressed safety signals, and delayed action make generalized public distrust of vaccine safety assurances rational. These documented past failures do not validate the specific claim under analysis that childhood vaccines were never properly tested in placebo trials, as the evidence shows they were, using scientifically and ethically appropriate controls.

STRONGEST SUPPORTING ARGUMENT The 1954 Salk polio field trial randomized over 1.3 million children to vaccine, placebo (a reddish liquid without virus), or observation, establishing both efficacy and safety and serving as a foundational example.[4] Subsequent vaccines such as varicella were tested against placebos containing stabilizers and trace manufacturing residuals, with follow-up data spanning years showing no severe attributable effects; rotavirus vaccines used inactive-ingredient solutions as controls.[1] Ethical guidelines from WHO, FDA, and experts including Arthur Caplan state that once an effective vaccine exists, withholding it to use an inert placebo in children is often unethical because it violates equipoise and exposes participants to preventable disease. Biostatisticians and vaccinologists (Jeffrey Morris, Kathryn Edwards, Charlotte Moser) note that safety is determined by the full body of evidence—pre-licensure trials, millions of doses in observational studies, and active surveillance systems—not any single inert-placebo arm. Matching controls (adjuvant without antigen) isolate the immunizing component while preserving blinding, directly addressing the “narrow definition” critique.[2][1]

STRONGEST COUNTERARGUMENT Many package inserts and pivotal trials for vaccines currently on the schedule list control arms containing aluminum adjuvants, other antigens, or vaccine components rather than pure saline, so they do not establish a true “nothing at all” baseline for overall health outcomes or adjuvant-related effects. ICAN’s FOIA-obtained documents and reviews of licensure data show that few if any of the exact formulations given to infants today were tested against inert saline in the precise pre-licensure double-blind manner demanded; this leaves open questions about cumulative impacts across the full schedule. Requiring inert placebos only for new vaccines (as current HHS policy moves toward) implicitly concedes that prior approaches left certain risk-profile data incomplete, and post-licensure systems like VAERS are acknowledged even by defenders as passive and underpowered for detecting rare signals without additional rigorous studies.[1][6]

BOTTOM LINE The article’s core claims are correct: the specific refrain that “not a single childhood vaccine has ever been through a double-blind placebo-based trial” is misleading because it ignores both the placebo-controlled trials that did occur and the ethical/scientific reasons for using active or matched controls in later studies. The piece accurately describes Bigtree’s and Kennedy’s statements and the mainstream scientific rebuttal. Past institutional failures in pharma regulation justify skepticism and scrutiny of new products, but they do not make the absolute claim about absent testing true.

CREDIBILITY: 8 EVIDENCE: 9 BIAS: CENTER-LEFT — FactCheck.org is rated Lean Left by AllSides; the article robustly defends the existing vaccine development and regulatory framework against high-profile critics now influencing HHS policy. CATEGORY: Health & Science

SOURCES

1. FactCheck.org, https://www.factcheck.org/2026/04/the-persistent-misleading-claim-that-vaccines-arent-properly-tested-for-safety/
2. Johns Hopkins International Vaccine Access Center, https://publichealth.jhu.edu/ivac/vaccine-safety-trials-and-placebos-an-explainer
3. Children’s Hospital of Philadelphia, https://www.chop.edu/vaccine-update-healthcare-professionals/newsletter/75-years-placebo-controlled-vaccine-testing-us
4. AAP Fact Check, https://www.aap.org/en/news-room/fact-checked/fact-checked-childhood-vaccines-are-carefully-studiedincluding-with-placebosto-ensure-theyre-safe-and-effective/
5. NPR, https://www.npr.org/sections/shots-health-news/2025/05/01/nx-s1-5383172/rfk-jr-placebo-vaccine-testing-studies
6. CNN/WRAL reporting on Kennedy claims, https://www.wral.com/story/despite-kennedy-s-claims-vaccines-have-been-tested-in-placebo-controlled-studies-nearly-260-of-them/22039610/
7. History of Vaccines (polio trial), https://historyofvaccines.org/blog/randomized-clinical-trials-for-vaccine-safety-efficacy-and-effectiveness/